<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[ADA2026 - Pfizer - Berobenatid]]></title><description><![CDATA[<p dir="auto">Der er ADA2026 (American Diabetes Association) konference i weekenden. Pfizer har sendt en semi-interessant pressemeddelelse ud. Ellers synes jeg det indtil videre forventligt har vaeret lidt smaat med nyheder sammenlignet med ADA2025.</p>
<p dir="auto">Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide<br />
<a href="https://www.pfizer.com/news/press-release/press-release-detail/robust-phase-2b-efficacy-and-favorable-tolerability-support" rel="nofollow ugc">https://www.pfizer.com/news/press-release/press-release-detail/robust-phase-2b-efficacy-and-favorable-tolerability-support</a></p>
<p dir="auto">Den stoerste nyhed fra ADA2026 er desvaerre den her:<br />
Police Remove Diabetes Experts From Conference for Distributing Critique of Trump Administration<br />
<a href="https://www.nytimes.com/2026/06/05/well/ada-conference-diabetes-trump.html" rel="nofollow ugc">https://www.nytimes.com/2026/06/05/well/ada-conference-diabetes-trump.html</a></p>
<p dir="auto">First They Came / Als sie kamen ...</p>
<hr />
<p dir="auto">Nedenfor pressemeddelelser fra de andre. Jeg kan ikke se, at Roche har sendt noget ud:<br />
<a href="https://www.roche.com/media/releases" rel="nofollow ugc">https://www.roche.com/media/releases</a></p>
<p dir="auto">People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data<br />
<a href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916561" rel="nofollow ugc">https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916561</a></p>
<p dir="auto">Novo Nordisk's investigational zenagamtide shows significant HbA1C reductions with up to 14.6% weight loss in adults with type 2 diabetes - presented at ADA 2026<br />
<a href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916559" rel="nofollow ugc">https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916559</a></p>
<p dir="auto">Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications<br />
<a href="https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-drove-substantial-improvements" rel="nofollow ugc">https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-drove-substantial-improvements</a></p>
<p dir="auto">New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity<br />
<a href="https://www.globenewswire.com/news-release/2026/06/05/3307625/0/en/New-data-from-Phase-2-ZUPREME-1-trial-at-the-American-Diabetes-Association-2026-Scientific-Sessions-further-support-potential-of-petrelintide-to-redefine-the-weight-management-expe.html" rel="nofollow ugc">https://www.globenewswire.com/news-release/2026/06/05/3307625/0/en/New-data-from-Phase-2-ZUPREME-1-trial-at-the-American-Diabetes-Association-2026-Scientific-Sessions-further-support-potential-of-petrelintide-to-redefine-the-weight-management-expe.html</a></p>
<p dir="auto">Web cast fra Novo Nordisk her natten mellem soendag og mandag:<br />
<a href="https://edge.media-server.com/mmc/p/xxkg9u3t/" rel="nofollow ugc">https://edge.media-server.com/mmc/p/xxkg9u3t/</a></p>
<p dir="auto"><img src="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/132625_bafkreifs6blvddjhhrto7m4vpiadsitwx2eus73fn6qpixfeeyeneeuuue.png" alt="132625_bafkreifs6blvddjhhrto7m4vpiadsitwx2eus73fn6qpixfeeyeneeuuue.png" class=" img-fluid img-markdown" /><br />
<img src="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/132625_bafkreiaofq3mio4psgkycixomy7xhlpz3v524xn72vzeipgacqypfwi7u4.png" alt="132625_bafkreiaofq3mio4psgkycixomy7xhlpz3v524xn72vzeipgacqypfwi7u4.png" class=" img-fluid img-markdown" /></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448280/ada2026-pfizer-berobenatid</link><generator>RSS for Node</generator><lastBuildDate>Tue, 09 Jun 2026 15:31:57 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448280.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 06 Jun 2026 18:58:49 GMT</pubDate><ttl>60</ttl></channel></rss>